CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, today ...
Only 1 infant with respiratory distress syndrome had a significant intracranial bleed with subsequent post-hemorrhagic hydrocephalus necessitating ventriculo-peritoneal shunt placement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback